Birkeroed, Denmark

Anne-Mette Haahr

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 7.6

ph-index = 4

Forward Citations = 52(Granted Patents)


Location History:

  • Bikeroed, DK (2016)
  • Birkeroed, DK (2013 - 2018)

Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Anne-Mette Haahr

Introduction

Anne-Mette Haahr is a prominent inventor based in Birkeroed, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that are resistant to abuse. With a total of 6 patents to her name, her work is recognized for its impact on medication safety and efficacy.

Latest Patents

Among her latest innovations are pharmaceutical compositions designed for oral administration that are resistant to abuse. These immediate-release formulations aim to provide effective treatment while minimizing the potential for misuse. Her dedication to creating safer pharmaceutical options is evident in her repeated focus on this critical area.

Career Highlights

Anne-Mette Haahr has built a successful career at Egalet Ltd., where she continues to push the boundaries of pharmaceutical research. Her expertise and innovative mindset have positioned her as a leader in her field, contributing to advancements that prioritize patient safety.

Collaborations

Throughout her career, Anne-Mette has collaborated with notable colleagues, including Jan Martin Oevergaard and Karsten Lindhardt. These partnerships have fostered a dynamic environment for innovation and have led to the development of groundbreaking pharmaceutical solutions.

Conclusion

Anne-Mette Haahr's contributions to the pharmaceutical industry exemplify her commitment to innovation and safety. Her work not only enhances the efficacy of medications but also addresses critical issues related to abuse potential.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…